We are live on ! Find out more
IDYA icon

IDEAYA Biosciences

84 hedge funds and large institutions have $533M invested in IDEAYA Biosciences in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 43 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 17

3.5% more ownership

Funds ownership: 73.69%77.19% (+3.5%)

5% less capital invested

Capital invested by funds: $558M → $533M (-$25.3M)

6% less funds holding

Funds holding: 8984 (-5)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

Holders
84
Holders Change
-5
Holders Change %
-5.62%
% of All Funds
1.46%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
7
Increased
43
Reduced
17
Closed
12
Calls
$10K
Puts
Net Calls
+$10K
Net Calls Change
-$86K
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$1.8M +$1.5M +72,930 +561%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.65M +$612K +29,799 +61%
ACM
28
ACT Capital Management
Pennsylvania
$1.45M +$1.42M +69,200 New
Massachusetts Financial Services
29
Massachusetts Financial Services
Massachusetts
$1.45M +$12.1K +591 +0.9%
EGI
30
EAM Global Investors
California
$1.44M -$483K -23,531 -25%
Renaissance Technologies
31
Renaissance Technologies
New York
$1.44M +$162K +7,900 +13%
TD Asset Management
32
TD Asset Management
Ontario, Canada
$1.42M +$409K +19,897 +52%
Charles Schwab
33
Charles Schwab
California
$1.38M +$448K +21,814 +50%
JAMONY
34
Jacob Asset Management of New York
California
$1.08M -$47.2K -2,300 -4%
EI
35
EAM Investors
California
$1.02M -$344K -16,761 -26%
SCM
36
Sio Capital Management
New York
$1.01M
Fidelity Investments
37
Fidelity Investments
Massachusetts
$939K +$916K +44,589 +35,109%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$812K +$248K +12,067 +45%
Goldman Sachs
39
Goldman Sachs
New York
$786K +$62.7K +3,054 +9%
Ensign Peak Advisors
40
Ensign Peak Advisors
Utah
$775K
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$616K +$221K +10,763 +58%
Wells Fargo
42
Wells Fargo
California
$529K +$106K +5,155 +26%
AQR Capital Management
43
AQR Capital Management
Connecticut
$522K -$128K -6,213 -20%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$509K +$194K +9,454 +64%
Two Sigma Investments
45
Two Sigma Investments
New York
$493K -$1.94M -94,278 -80%
UBS Group
46
UBS Group
Switzerland
$487K +$223K +10,846 +88%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$464K
MFIM
48
Mesirow Financial Investment Management
Illinois
$422K +$413K +20,084 New
JP Morgan Chase
49
JP Morgan Chase
New York
$416K -$247K -12,013 -38%
Deutsche Bank
50
Deutsche Bank
Germany
$350K +$130K +6,335 +61%

IDYA Hedge Fund Activity: Q2 2021 in Review

84 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q2 2021, worth a combined $533M — down 4.5% from $558M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of IDYA and 7 opened new positions — a net loss of 5 holders — while 17 trimmed existing stakes and 43 added.

The largest buyer was BlackRock, adding an estimated $24.6M. The largest seller was BVF Inc, exiting entirely with an estimated $61.3M sold.

  • 84 institutional investors held IDEAYA Biosciences (IDYA) as of Q2 2021, down from 89 in Q1 2021.
  • Funds reported $533M of IDEAYA Biosciences stock for Q2 2021, down 4.5% quarter-over-quarter.
  • 7 funds opened new IDEAYA Biosciences positions in Q2 2021 and 12 closed out, a net change of -5 holders.
  • The largest IDEAYA Biosciences buyer in Q2 2021 was BlackRock, an estimated $24.6M added.
  • The largest IDEAYA Biosciences seller in Q2 2021 was BVF Inc, an estimated $61.3M sold.

Based on aggregated 13F filings for Q2 2021.